GlucoTrack (NASDAQ:GCTK) Issues Quarterly Earnings Results

GlucoTrack (NASDAQ:GCTK) posted its earnings results on Thursday. The company reported $2.65 earnings per share for the quarter, FiscalAI reports.

GlucoTrack Price Performance

GlucoTrack stock traded down $0.01 during mid-day trading on Friday, reaching $0.66. 189,886 shares of the company were exchanged, compared to its average volume of 3,308,537. The firm has a market cap of $1.29 million, a PE ratio of -0.01 and a beta of 0.78. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.61 and a quick ratio of 1.61. The company has a fifty day simple moving average of $0.93 and a 200-day simple moving average of $2.99. GlucoTrack has a 12 month low of $0.58 and a 12 month high of $15.90.

Institutional Trading of GlucoTrack

Large investors have recently modified their holdings of the stock. Ikarian Capital LLC bought a new position in shares of GlucoTrack in the fourth quarter worth $177,000. Boothbay Fund Management LLC bought a new stake in GlucoTrack during the fourth quarter worth about $52,000. Finally, Bank of America Corp DE grew its stake in GlucoTrack by 102,125.0% during the second quarter. Bank of America Corp DE now owns 4,089 shares of the company’s stock worth $25,000 after buying an additional 4,085 shares in the last quarter. 10.92% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of GlucoTrack in a research note on Tuesday, April 21st. One research analyst has rated the stock with a Sell rating, According to MarketBeat, GlucoTrack has an average rating of “Sell”.

GlucoTrack Company Profile

GlucoTrack, Inc, a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc and changed its name to GlucoTrack, Inc in November 2021. GlucoTrack, Inc was founded in 2001 and is based in Rutherford, New Jersey.